New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A2544

Introduced
2/14/22  

Caption

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Companion Bills

NJ S2143

Same As Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Similar Bills

NJ A3668

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

NJ S2143

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

TN SB0421

AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.

TN HB1239

AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.

TN HB2308

AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63 and Title 68, relative to the use of buprenorphine products.

TN SB2297

AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63 and Title 68, relative to the use of buprenorphine products.

VT H0222

An act relating to reducing overdoses

CA AB395

Substance use treatment providers.